Literature DB >> 31933880

Long non-coding RNA SNHG1 promotes Cyclin D1-mediated proliferation in pancreatic cancer by acting as a ceRNA of miR-195.

Dong Li1, Xuming Zhang1, Yuxi Yang1, Yi Shen2, Qibing Zhang1, Hong Liu1, Xiaofeng Li1, Chunqiu Zhang1, Pengyu Liu1, Xiangzheng Qin3.   

Abstract

Pancreatic cancer (PCa) is one of the most fatal cancers worldwide. Recently, many studies have confirmed that long non-coding RNAs (lncRNAs) play crucial roles in the development of many human cancers, including PCa. The purpose of the present study was to investigate the biological role and underlying mechanisms of lncRNA small nucleolar RNA host gene 1 (SNHG1) in PCa progression. The results demonstrated that the expression levels of SNHG1 were increased in PCa cell lines and human tissue samples. High SNHG1 expression was notably correlated with adverse characteristics and poor survival of PCa patients. Knockdown of SNHG1 suppressed PCa cell proliferation in vitro and PCa tumor growth in vivo, and these effects might be associated with the induction of cell cycle arrest. We further confirmed that, in PCa cells, SNHG1 can negatively regulate miR-195 expression by acting as a ceRNA, and Cyclin D1 is a direct target of miR-195. Overexpression of miR-195 abrogated the oncogenic role of SNHG1 in PCa cells. Collectively, our results identified SNHG1 as a novel oncogenic lncRNA in PCa, and indicated that SNHG1/miR-195/Cyclin D1 axis might be a potential therapeutic target for PCa patients. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Long non-coding RNA; SNHG1; cell cycle; competing endogenous RNA; microRNA-195; pancreatic cancer

Year:  2019        PMID: 31933880      PMCID: PMC6945185     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Tuning in to the signals: noncoding sequence conservation in vertebrate genomes.

Authors:  Greg Elgar; Tanya Vavouri
Journal:  Trends Genet       Date:  2008-05-29       Impact factor: 11.639

3.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

4.  Long non-coding RNA SNHG1 promotes cell proliferation and tumorigenesis in colorectal cancer via Wnt/β-catenin signaling.

Authors:  Hong Qi; Junhua Wang; Fenghua Wang; Hongmei Ma
Journal:  Pharmazie       Date:  2017-07-03       Impact factor: 1.267

5.  Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer.

Authors:  Ling Ma; Feng Wang; Chong Du; Zhengkui Zhang; Huahu Guo; Xuehai Xie; Hongqiao Gao; Yan Zhuang; Marko Kornmann; Hong Gao; Xiaodong Tian; Yinmo Yang
Journal:  Oncol Rep       Date:  2018-01-02       Impact factor: 3.906

6.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1.

Authors:  V Baldin; J Lukas; M J Marcote; M Pagano; G Draetta
Journal:  Genes Dev       Date:  1993-05       Impact factor: 11.361

Review 7.  Small nucleolar RNA host gene 1: A new biomarker and therapeutic target for cancers.

Authors:  Lining Huang; Xingming Jiang; Zhidong Wang; Xiangyu Zhong; Sheng Tai; Yunfu Cui
Journal:  Pathol Res Pract       Date:  2018-08-02       Impact factor: 3.250

8.  Expression of Long Non-Coding RNA (lncRNA) Small Nucleolar RNA Host Gene 1 (SNHG1) Exacerbates Hepatocellular Carcinoma Through Suppressing miR-195.

Authors:  Hui Zhang; Dong Zhou; Mingang Ying; Minyong Chen; Peng Chen; Zhaoshuo Chen; Fan Zhang
Journal:  Med Sci Monit       Date:  2016-12-09

9.  Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.

Authors:  Yun Cui; Fuming Zhang; Chunkai Zhu; Liang Geng; Tongde Tian; Huaimin Liu
Journal:  Oncotarget       Date:  2017-03-14

10.  Long noncoding RNA SNHG1 promotes cell proliferation through PI3K/AKT signaling pathway in pancreatic ductal adenocarcinoma.

Authors:  Yalu Zhang; Rundong Zhang; Guopei Luo; Kaixing Ai
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

View more
  3 in total

1.  The long non-coding RNA SNHG1 attenuates chondrocyte apoptosis and inflammation via the miR-195/IKK-α axis.

Authors:  Qi Wang; Feng Deng; Jiao Li; Lei Guo; Kefeng Li
Journal:  Cell Tissue Bank       Date:  2022-07-07       Impact factor: 1.522

2.  LncRNA SNHG1 Promotes the Progression of Pancreatic Cancer by Regulating FGFR1 Expression via Competitively Binding to miR-497.

Authors:  Shihong Chen; Wenyi Guo; Mingyang Meng; Dong Wu; Tao Zhou; Lei Wang; Jianwei Xu
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

3.  Long non-coding RNA SNHG1 suppresses cell migration and invasion and upregulates SOCS2 in human gastric carcinoma.

Authors:  Shanshan Wang; Haibo Han; Junling Meng; Wei Yang; Yunwei Lv; Xianzi Wen
Journal:  Biochem Biophys Rep       Date:  2021-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.